New Key Statistics Module, Z-Score and F-Score
NAS:CNTA Key Ratios
Market Cap $ M | 1,001.61 |
Enterprise Value $ M | 889.20 |
P/E(ttm) | -- |
PE Ratio without NRI | -- |
Forward PE Ratio | -- |
Price/Book | 3.99 |
Price/Sales | 136.43 |
Price/Free Cash Flow | -- |
Price/Owner Earnings | -- |
Payout Ratio % | -- |
Revenue (TTM) $ M | 6.00 |
EPS (TTM) $ | -1.56 |
Beneish M-Score | 0 |
10-y EBITDA Growth Rate % | -- |
5-y EBITDA Growth Rate % | -- |
y-y EBITDA Growth Rate % | -- |
EV-to-EBIT | -5.35 |
EV-to-EBITDA | -5.38 |
PEG | -- |
Shares Outstanding M | 111.12 |
Net Margin (%) | -2,204.66 |
Operating Margin % | -2,499.39 |
Pre-tax Margin (%) | -2,570.28 |
Quick Ratio | 8.00 |
Current Ratio | 8.00 |
ROA % (ttm) | -38.18 |
ROE % (ttm) | -53.89 |
ROIC % (ttm) | -326.22 |
Dividend Yield % | -- |
Altman Z-Score | 1.62 |
CNTA Number of Guru Trades
CNTA Volume of Guru Trades
Gurus Latest Trades with NAS:CNTA
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
NAS:CNTA is held by these investors
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
Centessa Pharmaceuticals PLC Insider Transactions
No Available Data
News about NAS:CNTA
Total 0- 1